Akero Therapeutics Inc (AKRO)
19.66
-0.05
(-0.25%)
USD |
NASDAQ |
May 03, 16:00
19.64
-0.02
(-0.10%)
After-Hours: 20:00
Akero Therapeutics Free Cash Flow: -145.37M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -145.37M |
| September 30, 2023 | -122.25M |
| June 30, 2023 | -97.15M |
| March 31, 2023 | -94.27M |
| December 31, 2022 | -92.52M |
| September 30, 2022 | -93.70M |
| June 30, 2022 | -83.69M |
| March 31, 2022 | -84.21M |
| December 31, 2021 | -79.68M |
| September 30, 2021 | -76.38M |
| June 30, 2021 | -75.28M |
| Date | Value |
|---|---|
| March 31, 2021 | -77.83M |
| December 31, 2020 | -70.95M |
| September 30, 2020 | -59.20M |
| June 30, 2020 | -58.76M |
| March 31, 2020 | -41.50M |
| December 31, 2019 | -35.63M |
| September 30, 2019 | -26.05M |
| June 30, 2019 | -14.80M |
| March 31, 2019 | -14.73M |
| December 31, 2018 | -4.625M |
Free Cash Flow Range, Past 5 Years
-145.37M
Minimum
Dec 2023
-14.80M
Maximum
Jun 2019
-75.22M
Average
-77.83M
Median
Mar 2021
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -325.71M |
| 89bio Inc | -129.19M |
| Viking Therapeutics Inc | -54.87M |
| Eli Lilly and Co | -3.896B |
| Ionis Pharmaceuticals Inc | -335.52M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.63M |
| Cash from Investing (Quarterly) | 12.79M |
| Cash from Financing (Quarterly) | 0.502M |
| Free Cash Flow Per Share (Quarterly) | -0.8722 |
| Free Cash Flow Yield | -14.07% |